Thirteenth census of the United States taken in the year 1910 : Abstract of census. Statistics of population, agriculture, manufactures, and mining for the United States, the states, and principal cities, with supplement for Kansas containing statistics for the state, counties, cities, and other divisions.

At head of title: Department of Commerce and Labor. Bureau of the Census. E. Dana Durand, director.

Thirteenth census of the United States taken in the year 1910. Statistics for Hawaii containing statistics of population, agriculture, and manufactures for the territory, counties and cities.

At head of title: Department of commerce. Bureau of the census. E. Dana Durand, director. Appointed June 16, 1909; Resigned June 30, 1913. Wm. J. Harris, director. Appointed July 1, 1913.

Principles of political economy, and of population: including an examination of Mr. Malthus's essay on those subjects,

Mode of access: Internet.

Thirteenth census of the United States taken in the year 1910. Statistics for Kentucky containing statistics of population, agriculture, manufactures, and mining for the state, counties, cities, and other divisions. Reprint of the Supplement for Kentucky published in connection with the Abstract of the census.

At head of title: Department of commerce and labor. Bureau of the census. E. Dana Durand, director.

1980 census of population : alphabetical index of industries and occupations.

Previous ed. entered under: United States. Bureau of the Census.

1990 census of population and housing. Reference reports.

Mode of access: Internet.

State Prison of Southern Michigan, Jackson. Statistical Report with Movement of Population

Issued with Following Variations In Title: Michigan State Prison, Jackson. Statistical Report; Statistical Report; Quarterly Statistical Report

The problem of the immigrant; a brief discussion, with a summary of conditions, laws, and regulations governing the movement of population to and from the British empire, United States, France, Belgium, Switzerland, Germany, Italy, Austria-Hungary, Spain, Portugal, Netherlands, Denmark, Scandinavia and Russia:

Mode of access: Internet.

The problem of the immigrant : a brief discussion, with a summary of conditions, laws, and regulations governing the movement of population to and from the British empire, United States, France, Belgium, Switzerland, Germany, Italy, Austria-Hungary, Spain, Portugal, Netherlands, Denmark, Scandinavia and Russia /

Includes index.

Report of the first session of the Regional Conference on Population and Development in Latin America and the Caribbean: full integration of population dynamics into rights-based sustainable development with equality: key to the Cairo programme of action beyond 2014

Includes as annex the Montevideo Consensus on Population and Development

The development of population projections for the Turks and Caicos Islands 2012-2027

It is not possible to trace the early demographic development of the Turks and Caicos Islands due to lack of data, but what is evident from the limited historical data is that population developments beginning in 1921 and up to 1970 followed the same path as other Caribbean Islands. The Turks and Caicos Islands have experienced unprecedented population growth over the last twenty years due largely to the immigration of people from neighbouring countries seeking employment created by the development of tourism. Such rapid population changes for the small island group present many social, economic, environmental and political challenges. Population projections are essential so that policymakers and decision makers can make informed judgements about future strategies, policies and programmes.

Approximating persistence in a general class of population processes

We provide a general framework for estimating persistence in populations which may be affected by catastrophic events, and which are either unbounded or have very large ceilings. We model the population using a birth-death process modified to allow for downward jumps of arbitrary size. For such processes, it is typically necessary to truncate the process in order to make the evaluation of expected extinction times (and higher-order moments) computationally feasible. Hence, we give particular attention to the selection of a cut-off point at which to truncate the process, and we present a simple method for obtaining quantitative indicators of the suitability of a chosen cut-off. (c) 2005 Elsevier Inc. All rights reserved.

Some considerations on the design of population pharmacokinetic studies

The goal of this manuscript is to introduce a framework for consideration of designs for population pharmacokinetic orpharmacokinetic-pharmacodynamic studies. A standard one compartment pharmacokinetic model with first-order input and elimination is considered. A series of theoretical designs are considered that explore the influence of optimizing the allocation of sampling times, allocating patients to elementary designs, consideration of sparse sampling and unbalanced designs and also the influence of single vs. multiple dose designs. It was found that what appears to be relatively sparse sampling (less blood samples per patient than the number of fixed effects parameters to estimate) can also be highly informative. Overall, it is evident that exploring the population design space can yield many parsimonious designs that are efficient for parameter estimation and that may not otherwise have been considered without the aid of optimal design theory.

Analysis of population pharmacokinetic data using NONMEM and WinBUGS

The aim of this report is to describe the use of WinBUGS for two datasets that arise from typical population pharmacokinetic studies. The first dataset relates to gentamicin concentration-time data that arose as part of routine clinical care of 55 neonates. The second dataset incorporated data from 96 patients receiving enoxaparin. Both datasets were originally analyzed by using NONMEM. In the first instance, although NONMEM provided reasonable estimates of the fixed effects parameters it was unable to provide satisfactory estimates of the between-subject variance. In the second instance, the use of NONMEM resulted in the development of a successful model, albeit with limited available information on the between-subject variability of the pharmacokinetic parameters. WinBUGS was used to develop a model for both of these datasets. Model comparison for the enoxaparin dataset was performed by using the posterior distribution of the log-likelihood and a posterior predictive check. The use of WinBUGS supported the same structural models tried in NONMEM. For the gentamicin dataset a one-compartment model with intravenous infusion was developed, and the population parameters including the full between-subject variance-covariance matrix were available. Analysis of the enoxaparin dataset supported a two compartment model as superior to the one-compartment model, based on the posterior predictive check. Again, the full between-subject variance-covariance matrix parameters were available. Fully Bayesian approaches using MCMC methods, via WinBUGS, can offer added value for analysis of population pharmacokinetic data.

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

Background Our aim was to calculate the global burden of disease and risk factors for 2001, to examine regional trends from 1990 to 2001, and to provide a starting point for the analysis of the Disease Control Priorities Project (DCPP). Methods We calculated mortality, incidence, prevalence, and disability adjusted life years (DALYs) for 136 diseases and injuries, for seven income/geographic country groups. To assess trends, we re-estimated all-cause mortality for 1990 with the same methods as for 2001. We estimated mortality and disease burden attributable to 19 risk factors. Findings About 56 million people died in 2001. Of these, 10.6 million were children, 99% of whom lived in low-and-middle-income countries. More than half of child deaths in 2001 were attributable to acute respiratory infections, measles, diarrhoea, malaria, and HIV/AIDS. The ten leading diseases for global disease burden were perinatal conditions, lower respiratory infections, ischaemic heart disease, cerebrovascular disease, HIV/AIDS, diarrhoeal diseases, unipolar major depression, malaria, chronic obstructive pulmonary disease, and tuberculosis. There was a 20% reduction in global disease burden per head due to communicable, maternal, perinatal, and nutritional conditions between 1990 and 2001. Almost half the disease burden in low-and-middle-income countries is now from non-communicable diseases (disease burden per head in Sub-Saharan Africa and the low-and-middle-income countries of Europe and Central Asia increased between 1990 and 2001). Undernutrition remains the leading risk factor for health loss. An estimated 45% of global mortality and 36% of global disease burden are attributable to the joint hazardous effects of the 19 risk factors studied. Uncertainty in all-cause mortality estimates ranged from around 1% in high-income countries to 15-20% in Sub-Saharan Africa. Uncertainty was larger for mortality from specific diseases, and for incidence and prevalence of non-fatal outcomes. Interpretation Despite uncertainties about mortality and burden of disease estimates, our findings suggest that substantial gains in health have been achieved in most populations, countered by the HIV/AIDS epidemic in Sub-Saharan Africa and setbacks in adult mortality in countries of the former Soviet Union. our results on major disease, injury, and risk factor causes of loss of health, together with information on the cost-effectiveness of interventions, can assist in accelerating progress towards better health and reducing the persistent differentials in health between poor and rich countries.